{"id":"W4295817205","doi":"10.1016/j.annonc.2022.07.653","title":"525MO Updated efficacy and safety of lenvatinib (LEN) + pembrolizumab (pembro) vs treatment of physician’s choice (TPC) in patients (pts) with advanced endometrial cancer (aEC): Study 309/KEYNOTE-775","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Oncology; Internal medicine; Endometrial cancer; Gynecology; Family medicine; Medical physics; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009961302,0.0004371016,0.001150765,0.0003840379,0.0002546291,0.0007862018,0.0004106227,0.0008005716,0.01137514],"category_scores_gemma":[0.001707985,0.0003880008,0.002525088,0.0004227204,0.0002561324,0.0007511195,0.0002695986,0.001962876,0.001184466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008055381,"about_ca_system_score_gemma":0.0008492395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00196362,"about_ca_topic_score_gemma":0.005935833,"domain_scores_codex":[0.9995265,0.0002122009,0.00004159035,0.00008519905,0.00006949991,0.00006508274],"domain_scores_gemma":[0.9992658,0.0002287228,0.0002570467,0.00005823653,0.00005910141,0.0001309809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8607517,0.004539369,0.01532992,0.001912158,0.01034815,0.00009692652,0.00008672378,0.001195157,0.004533435,0.0002655449,0.007603093,0.09333787],"study_design_scores_gemma":[0.6694452,0.1680044,0.1170774,0.0006736569,0.02133082,0.0002987621,0.0001386893,0.001611333,0.002555047,0.0006257675,0.01815364,0.00008530138],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563821,0.01969234,0.0003047345,0.001485906,0.0006064365,0.0007496927,0.01025205,0.00009965667,0.01042715],"genre_scores_gemma":[0.979511,0.00535238,0.0005074688,0.001504071,0.000489269,0.0004484481,0.005343235,0.00001915898,0.006824865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01137514,"threshold_uncertainty_score":0.03805357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05058624724658811,"score_gpt":0.3731665568183526,"score_spread":0.3225803095717645,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}